Work

793 Receptor tyrosine kinase inhibition results in the regression of acral melanoma by targeting the tumor microenvironment

Year: 2024

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2024.06.809

Authors: E.A. Smith, R.L. Belote, N.E. Cruz, T.E. Mustafa, C. Becker, S. Alizada, T. Chan, T.A. Seasor, M. Balatico, E. Cortes-Sanchez, D. Deacon, D. Lum, J.R. Hyngstrom, A.H. Grossman, R.M. White, T.A. Zangle, R. Judson-Torres

Institutions: University of Utah, Huntsman Cancer Institute, The Ohio State University, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4400824951

FWCI:

Cites:

Cited by:

Related to: 10